ETC
STRO icon

Exchange Traded Concepts’s Sutro Biopharma STRO Stock Holding History

Exchange Traded Concepts’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,662
Closed -$88.9K – 1500
2025
Q1 		$88.9K Buy
13,662
+9,136
+202% +$144K ﹤0.01% 1192
2024
Q4 		$83.3K Hold
4,526
– – ﹤0.01% 1175
2024
Q3 		$157K Sell
4,526
-894
-16% -$35K ﹤0.01% 1054
2024
Q2 		$159K Sell
5,420
-1,686
-24% -$66.7K ﹤0.01% 899
2024
Q1 		$401K Buy
7,106
+3,520
+98% +$155K 0.01% 680
2023
Q4 		$154K Buy
3,586
+910
+34% +$28.9K ﹤0.01% 829
2023
Q3 		$92.9K Buy
2,676
+115
+4% +$5.01K ﹤0.01% 924
2023
Q2 		$119K Buy
+2,561
New +$127K ﹤0.01% 911

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Exchange Traded Concepts's STRO Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 13,662 shares — an estimated $88.9K sold.

Exchange Traded Concepts first reported a position in STRO in Q2 2023 and held it in 8 quarters. The position peaked at $401K in Q1 2024. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 13,662 Sutro Biopharma shares in Q2 2025, an estimated $88.9K.
  • Exchange Traded Concepts first reported a position in Sutro Biopharma in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Sutro Biopharma position peaked at $401K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.